Multidisciplinary Lung Cancer Tumor Board: A Case-Based Discussion Spanning Bread-and-Butter through the Gray Zone

The management of locally advanced lung cancer increasingly relies on multidisciplinary collaboration. Advances in neoadjuvant and perioperative chemoimmunotherapy have significantly improved outcomes for patients with resectable non-small cell lung cancer. Therefore, timely evaluation of medical operability, surgical resectability and the integration of genomic and molecular biomarkers is essential to guide patients toward appropriate operative or non-operative pathways. This activity provides a brief review of locally advanced non-small cell lung cancer through the perspectives of a thoracic surgeon, medical oncologist and radiation oncologist, culminating in rigorous case-based, multidisciplinary discussion.

Topics:

  1. Multidisciplinary Lung Cancer Tumor Board: A Case-Based Discussion Spanning Bread-and-Butter through the Gray Zone
    Neal S. McCall, MD - Moderator
    Evan T. Alicuben, MD
    Ticiana A. Leal, MD
    Jeffrey D. Bradley, MD, FASTRO
  2. Q and A
    Neal S. McCall, MD - Moderator
    Full Panel

This activity is available from December 23, 2025, through 11:59 p.m. Eastern time on December 22, 2027. 

The content was originally presented and recorded at the 2025 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of radiation oncologists. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patients with clearly resectable and clearly unresectable lung cancer.
  • Recognize the importance of integrating next-generation sequencing and molecular data into management decisions. 
  • Appreciate best-practices in delivering definitive chemoradiation for patients with unresectable non-small cell lung cancer. 
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
12/23/2025
Course expires: 
12/22/2027
Cost:
$149.00
Rating: 
0
  • Neal Sean McCall, MD, is employed by UPMC Hillman Cancer Center. Dr. McCall receives honoraria from RefleXion. 
  • Evan T. Alicuben, MD, is employed by University of Pittsburgh Medical Center.
  • Ticiana A. Leal, MD, is employed by Winship Cancer Institute of Emory University. Dr. Leal receives compensation from Amgen. Dr. Leal receives honoraria from AbbVie, Catalyst, Eisai, Roche/Genentech, Novartis, Jazz, Janssen, Novocure, Merck, AstraZeneca, Amgen, Pfizer, Regeneron, Takeda, BMS and Sanofi. Dr. Leal receives grant/research funding from Daiichi Sankyo. 
  • Jeffrey D. Bradley, MD, FASTRO, is employed by University of Pennsylvania/Abramson Cancer Center. Dr. Bradley receives travel expenses from AstraZeneca, honoraria from Genentech, Inc., serves in an uncompensated role with Mevion Medical Systems, Inc. and receives grant/research funding from Varian, Inc. 

All relevant financial relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

  • Nonmember: $149
  • Member: $99
  • Member-in-Training: $49
  • Student/Graduate Student/PGY-1 Member: $49
  • Postdoctoral Fellow Member: $49

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date. 

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until December 22, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date. 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.